Report #2886155

Received Feb 19, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: NE
Recovered: Unknown
Vaccinated: Dec 17, 2025
Onset: Dec 17, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	2A3HY	LA

Symptoms (1)

Product preparation issue

Symptom narrative

The diluent was administered only; The diluent was administered only; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number 2A3HY, expiry date 26-APR-2027) for prophylaxis. On 17-DEC-2025, the patient received the 1st dose of Shingrix (left deltoid). On 17-DEC-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: The diluent was administered only) and inappropriate dose of vaccine administered (Verbatim: The diluent was administered only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 19-DEC-2025 The health care professional reported that the employee was trainee and did not mix the medication, only diluent was administered.